# Clearside Biomedical Inc. (CLSD) Source: https://www.quantisnow.com/company/CLSD Generated: 2026-11-11T21:55:31.329Z - Ticker: CLSD - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - IPO year: 2016 - Website: clearsidebio.com ## About Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion. The company was incorporated in 2011 and is headquartered in Alpharetta, Georgia. ## Latest CLSD news and filings - 2025-12-15 21:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6316061) - 2025-12-15 21:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6316053) - 2025-12-15 21:09 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6316046) - 2025-12-15 21:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6316018) - 2025-12-15 21:06 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6316007) - 2025-12-15 21:05 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6315979) - 2025-12-15 21:04 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6315963) - 2025-12-15 21:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6315952) - 2025-12-15 21:02 UTC [SEC Form POS AM filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clearside-biomedical-inc-6315913) - 2025-12-15 21:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6315900) - 2025-12-15 21:01 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clearside-biomedical-inc-6315893) - 2025-12-15 21:01 UTC [SEC Form POS AM filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clearside-biomedical-inc-6315884) - 2025-12-08 21:32 UTC [SEC Form 8-K] [SEC Form 8-K filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-clearside-biomedical-inc-6307226) - 2025-12-08 21:18 UTC [SEC Form 25 filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-clearside-biomedical-inc-6307100) - 2025-11-25 21:06 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-regulation-fd-disclosure-6293536) - 2025-11-24 12:05 UTC [Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process](https://www.quantisnow.com/insight/clearside-biomedical-to-pursue-strategic-sale-of-its-business-through-6291017) - 2025-11-14 21:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-clearside-biomedical-inc-6280514) - 2025-10-07 20:10 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-other-events-6226256) - 2025-09-11 11:24 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-amendments-to-articles-6197292) - 2025-09-11 11:20 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-amendments-to-articles-6197286) - 2025-09-08 11:16 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-entry-into-a-6192483) - 2025-09-03 20:30 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-6188208) - 2025-08-14 20:05 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-notice-of-delisting-6166049) - 2025-08-08 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-clearside-biomedical-inc-6156226) - 2025-08-04 12:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-clearside-biomedical-inc-6143997) - 2025-07-25 20:11 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-clearside-biomedical-inc-6133048) - 2025-07-23 11:05 UTC [Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada](https://www.quantisnow.com/insight/clearside-biomedical-announces-approval-of-xipere-suprachoroidal-treatment-for-uveitic-6128967) - 2025-07-18 12:10 UTC [Analyst Downgrade] [Clearside Biomedical downgraded by Stifel with a new price target](https://www.quantisnow.com/insight/clearside-biomedical-downgraded-by-stifel-with-a-new-price-target-6124972) - 2025-07-18 12:08 UTC [Analyst Downgrade] [Clearside Biomedical downgraded by Chardan Capital Markets](https://www.quantisnow.com/insight/clearside-biomedical-downgraded-by-chardan-capital-markets-6124968) - 2025-07-18 12:08 UTC [Analyst Downgrade] [Clearside Biomedical downgraded by H.C. Wainwright](https://www.quantisnow.com/insight/clearside-biomedical-downgraded-by-hc-wainwright-6124967) - 2025-07-17 11:15 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-costs-associated-with-6122963) - 2025-07-17 11:05 UTC [Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline](https://www.quantisnow.com/insight/clearside-biomedical-announces-plan-to-explore-strategic-alternatives-to-advance-6122956) - 2025-05-30 20:05 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-amendments-to-articles-6064950) - 2025-05-21 11:05 UTC [Conference Announcement] [Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum](https://www.quantisnow.com/insight/clearside-biomedical-to-participate-in-a-fireside-chat-at-the-6051575) - 2025-05-15 20:15 UTC [SEC Form S-8] [SEC Form S-8 filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-clearside-biomedical-inc-6042537) - 2025-05-15 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-clearside-biomedical-inc-6042117) - 2025-05-14 20:10 UTC [SEC Form 8-K] [Clearside Biomedical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clearside-biomedical-inc-filed-sec-form-8-k-results-of-operations-6038952) - 2025-05-08 11:05 UTC [Earnings Date] [Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025](https://www.quantisnow.com/insight/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-6025869) - 2025-05-01 11:05 UTC [Conference Announcement] [Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference](https://www.quantisnow.com/insight/clearside-biomedical-to-participate-in-a-fireside-chat-at-the-6011969) - 2025-04-18 12:05 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Clearside Biomedical Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-clearside-biomedical-inc-5993284) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CLSD - Earnings history: https://www.quantisnow.com/earnings/CLSD - Dividend history: https://www.quantisnow.com/dividends/CLSD - Insider transactions: https://www.quantisnow.com/insiders/CLSD - Options chain: https://www.quantisnow.com/options/CLSD - SEC 8-K filings only: https://www.quantisnow.com/company/CLSD/8-k - RSS and alerts for CLSD: https://www.quantisnow.com/docs/rss-feeds.md